Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium

American Journal of Pathology

Volumn 155, Issue 2, 1999, Pages 461-472

  Kim, Young J ^a   Borsig, Lubor ^a   Han, Hui Ling ^a   Varki, Nissi M ^a   Varki, Ajit ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; LIGAND; MUCIN; SELECTIN; SIALIC ACID; SIALOGLYCOPROTEIN;

ARTICLE; CANCER GROWTH; CELL ADHESION; COLON CARCINOMA; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; THROMBOCYTE;

EID: 0032771908     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65142-5     Document Type: Article

References (65)

1. Rosen SD, Bertozzi CR: The selectins and their ligands. Curr Opin Cell Biol 1994, 6:663-673
2. Lasky LA: Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu Rev Biochem 1995, 64:113-139
3. Ley K, Tedder TF: Leukocyte interactions with vascular endothelium: New insights into selectin-mediated attachment and rolling. J Immunol 1995, 155:525-528
4. Nelson RM, Venot A, Bevilacqua MP, Linhardt RJ, Stamenkovic I: Carbohydrate-protein interactions in vascular biology. Annu Rev Cell Biol 1995, 11:601-631
5. Tedder TF, Steeber DA, Chen A, Engel P: The selectins: vascular adhesion molecules. FASEB J 1995, 9:866-873
6. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 1996, 272:60-66
7. Crocker PR, Feizi T: Carbohydrate recognition systems: functional triads in cell-cell interactions. Curr Opin Struct Biol 1996, 6:679-691
8. Hynes RO, Wagner DD: Genetic manipulation of vascular adhesion molecules in mice. J Clin Invest 1996, 98:2193-2195
9. Kansas GS: Selectins and their ligands: current concepts and controversies. Blood 1996, 88:3259-3287
10. Lowe JB, Ward PA: Therapeutic inhibition of carbohydrate-protein interactions in vivo. J Clin Invest 1997, 99:822-826
11. McEver RP, Cummings RD: Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997, 100:485-492
12. Varki A: Selectin ligands: will the real ones please stand up? J Clin Invest 1997, 99:158-162
13. Rosen SD, Bertozzi CR: Leukocyte adhesion: two selectins converge on sulphate. Curr Biol 1996, 6:261-264
14. Vestweber D: Ligand-specificity of the selectins. J Cell Biochem 1996, 61:585-591
15. Sassetti C, Tangemann K, Singer MS, Kershaw DB, Rosen SD: Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34. J Exp Med 1998, 187:1965-1975
16. Devine PL, McKenzie IFC: Mucins: structure, function, and associations with malignancy. BioEssays 1992, 14:619-625
17. Carraway KL, Hull SR: Cell surface mucin-type glycoproteins and mucin-like domains. Glycobiology 1991, 1:131-138
18. Gibson RM, Kansas GS, Tedder TF, Furie B, Furie BC: Lectin and epidermal growth factor domains of P-selectin at physiologic density are the recognition unit for leukocyte binding. Blood 1995, 85:151-158
19. Crottet P, Kim YJ, Varki A: Subsets of sialylated, sulfated mucins of diverse origins are recognized by L-selectin: lack of evidence for unique oligosaccharide sequences mediating binding. Glycobiology 1996, 6:191-208
20. Nicholson MW, Barclay AN, Singer MS, Rosen SD, Van der Merwe PA: Affinity and kinetic analysis of L-selectin (CD62L) binding to glycosylation-dependent cell-adhesion molecule-1. J Biol Chem 1998, 273:763-770
21. Varki A: Selectin ligands. Proc Natl Acad Sci USA 1994, 91:7390-7397
22. Berg EL, Mullowney AT, Andrew DP, Goldberg JE, Butcher EC: Complexity and differential expression of carbohydrate epitopes associated with L-selectin recognition of high endothelial venules. Am J Pathol 1998, 152:469-477
23. Kim YS, Gum J, Brockhausen I: Mucin glycoproteins in neoplasia. Glycoconjugate J 1996, 13:693-707
24. Kim YJ, Varki A: Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconjugate J 1997, 14:569-576
25. Vavasseur F, Dole K, Yang J, Matta KL, Myerscough N, Corfield A, Paraskeva C, Brockhausen I: O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem 1994, 222:415-424
26. Yang J-M, Byrd JC, Siddiki BB, Chung Y-S, Okuno M, Sowa M, Kim YS, Matta KL, Brockhausen I: Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology 1994, 4:873-884
27. Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS: Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 1989, 49:197-204
28. x as a new tumor-associated antigen. Cancer Res 1984, 44:5279-5285
29. x antigen in liver metastases of human colorectal carcinoma. Cancer Res 1989, 49: 6883-6888
30. x antigen, is associated with metastatic potential of transitional cell carcinoma of the human urinary bladder. Biochem Biophys Res Commun 1991, 181:1218-1222
31. x antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study. Cancer Res 1993, 53:3632-3637
32. a as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 1995, 75:2051-2056
33. Fukuda M: Possible roles of tumor-associated carbohydrate antigens. Cancer Res 1996, 56:2237-2244
34. Ogawa J, Inoue H, Koide S: Expression of α-1,3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. Cancer Res 1996, 56:325-329
35. Kannagi R: Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconjugate J 1997, 14:577-584
36. x in colorectal cancer metastasis. Dis Colon Rectum 1997, 40:420-431
37. Zhang K, Baeckstrom D, Brevinge H, Hansson GC: Secreted MUC1 mucins lacking their cytoplasmic part, and carrying sialyl-Lewis a and x epitopes from a tumor cell line, and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J Cell Biochem 1996, 60:538-549
38. Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, Kannagi R: Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 1993, 53:354-361
39. Zhang K, Baeckström D, Hansson GC: A secreted mucin carrying sialyl-Lewis a from colon carcinoma cells binds to E-selectin and inhibits HL-60 cell adhesion. Int J Cancer 1994, 59:823-829
40. Bresalier RS, Niv Y, Byrd JC, Duh QY, Toribara NW, Rockwell RW, Dahiya R, Kim YS: Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 1991, 87:1037-1045
41. Biancone L, Araki M, Araki K, Vassalli P, Stamenkovic I: Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 1996, 183:581-587
42. Mannori G, Santoro D, Carter L, Corless C, Nelson RM, Bevilacqua MP: Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin. Am J Pathol 1997, 151:233-243
43. Kim YJ, Borsig L, Varki NM, Varki A: P-selectin deficiency attenuates tumor growth and metastasis Proc Natl Acad Sci USA 1998, 95: 9325-9330
44. Mannori G, Crottet P, Cecconi O, Hanasaki K, Aruffo A, Nelson RM, Varki A, Bevilacqua MP: Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin type glycoproteins. Cancer Res 1995, 55:4425-4431
45. Karpatkin S, Pearlstein E: Role of platelets in tumor cell metastases. Ann Intern Med 1981, 95:636-641
46. Gasic GJ: Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev 1984, 3:99-114
47. Weiss L: Principles of Metastasis. Orlando, FL, Academic Press, 1985
48. Fidler IJ: Critical factors in the biology of human cancer metastasis: Twenty-eighth G. H. A. Clowes Memorial Award lecture. Cancer Res 1990, 50:6130-6138
49. Honn KV, Tang DG, Crissman JD: Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev 1992, 11:325-351
50. Toyoshima M, Nakajima M, Yamori T, Tsuruo T: Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26. Cancer Res 1995, 55:767-773
51. Norgard KE, Han H, Powell L, Kriegler M, Varki A, Varki NM: Enhanced interaction of L-selectin with the high endothelial venule ligand via selectively oxidized sialic acids Proc Natl Acad Sci USA 1993, 90:1068-1072
52. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867
53. Koenig A, Jain R, Vig R, Norgard-Sumnicht KE, Matta KL, Varki A: Selectin inhibition: synthesis and evaluation of novel sialylated, sulfated and fucosylated oligosaccharides, including the major capping group of GlyCAM-1. Glycobiology 1997, 7:79-93
54. Sawada R, Tsuboi S, Fukuda M: Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 1994, 269:1425-1431
55. x carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells. Exp Cell Res 1995, 216:215-221
56. Majuri ML, Niemelä R, Tiisala S, Renkonen O, Renkonen R: Expression and function of α2,3-sialyl- and α1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors. Int J Cancer 1995, 63:551-559
57. Allen MH, Robinson MK, Stephens PE, MacDonald DM, Barker JNWN: E-selectin binds to squamous cell carcinoma and keratinocyte cell lines. J Invest Dermatol 1996, 106:611-615
58. Aruffo A, Dietsch MT, Wan H, Hellström KE, Hellström I: Granule membrane protein 140 (GMP 140) binds to carcinomas and carcinoma-derived cell lines. Proc Natl Acad Sci USA 1992, 89:2292-2296
59. Stone JP, Wagner DD: P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 1993, 92: 804-813
60. Goetz DJ, Ding H, Atkinson WJ, Vachino G, Camphausen RT, Cumming DA, Luscinskas FW: A human colon carcinoma cell line exhibits adhesive interactions with P-selectin under fluid flow via a PSGL-1-independent mechanism. Am J Pathol 1996, 149:1661-1673
61. Pottratz ST, Hall TD, Scribner WM, Jayaram HN, Natarajan V: P-selectin-mediated attachment of small cell lung carcinoma to endothelial cells. Am J Physiol Lung Cell Mol Physiol 1996, 27:L1918-L923
62. Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, Ruppert M, Zeller Y, Vestweber D, Stahel R, Sammar Mm Altevogt P: CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 1997, 89:3385-3395
63. Prakobphol A, Thomsson KA, Hansson GC, Rosen SD, Singer MS, Phillips NJ, Medzihradszky KF, Burlingame AL, Leffler H, Fisher SJ: Human low-molecular-weight salivary mucin expresses the sialyl lewisx determinant and has L-selectin ligand activity. Biochemistry 1998, 37:4916-4927
64. Borges E, Tietz W, Steegmaier M, Moll T, Hallmann R, Hamann A, Vestweber D: P-selectin glycoprotein ligand-1 (PSGL-1 ) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin. J Exp Med 1997, 185:573-578
65. x-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer. Cancer Res 1995, 55:928-933